SE435712B - Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav - Google Patents

Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav

Info

Publication number
SE435712B
SE435712B SE7703979A SE7703979A SE435712B SE 435712 B SE435712 B SE 435712B SE 7703979 A SE7703979 A SE 7703979A SE 7703979 A SE7703979 A SE 7703979A SE 435712 B SE435712 B SE 435712B
Authority
SE
Sweden
Prior art keywords
dialkylaminoisoalkylaminoacridines
nitro
salts
preparation
analogy procedure
Prior art date
Application number
SE7703979A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703979L (sv
Inventor
A Ledochowski
J Gieldanowski
C Radzikowski
C Kwasniewska-Rokicinska
B Wysocka-Skrzela
L Sawinska
M Medon
Original Assignee
Politechnika Gdanska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Gdanska filed Critical Politechnika Gdanska
Publication of SE7703979L publication Critical patent/SE7703979L/xx
Publication of SE435712B publication Critical patent/SE435712B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C07D219/12—Amino-alkylamino radicals attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
SE7703979A 1976-04-06 1977-04-05 Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav SE435712B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1976188528A PL101032B1 (pl) 1976-04-06 1976-04-06 Sposob otrzymywania 1-nitro-9-dwualkilo-aminoizoalkiloamiroakrydyn lub ich soli

Publications (2)

Publication Number Publication Date
SE7703979L SE7703979L (sv) 1977-10-07
SE435712B true SE435712B (sv) 1984-10-15

Family

ID=19976296

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703979A SE435712B (sv) 1976-04-06 1977-04-05 Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav

Country Status (12)

Country Link
US (1) US4150231A (enExample)
JP (1) JPS52151178A (enExample)
BE (1) BE852855A (enExample)
CH (1) CH634561A5 (enExample)
DE (1) DE2713103C2 (enExample)
FR (1) FR2347350A1 (enExample)
GB (1) GB1579588A (enExample)
HU (1) HU173105B (enExample)
NL (1) NL7703680A (enExample)
PL (1) PL101032B1 (enExample)
SE (1) SE435712B (enExample)
SU (2) SU683617A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335244A (en) * 1979-11-30 1982-06-15 Bristol-Myers Company Monolactate salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
JPS56127370A (en) * 1980-02-15 1981-10-06 Mitsui Toatsu Chem Inc Novel piperazine compound, its preparation and utilization
PL126407B1 (en) * 1980-04-23 1983-07-30 Politechnika Gdanska Process for preparing 1-nitro-9-hydroxyalkylaminoacridines or their salts
HU186383B (en) * 1981-02-27 1985-07-29 Biogal Gyogyszergyar Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
US6589961B2 (en) 2000-02-18 2003-07-08 New York Medical College 9-alkylamino-1-nitroacridine derivatives
DE60143020D1 (de) * 2000-02-18 2010-10-21 New York Medical College Valha 9-alkylamino-1-nitroacridin-derivate
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
CA2608144C (en) 2005-04-28 2012-11-13 Proteus Biomedical, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1962277A (en) * 1927-01-11 1934-06-12 Winthrop Chem Co Inc Basic nitroderivatives of 9-aminoacridines and process for preparing the same
DE1620473C3 (de) * 1964-05-25 1980-03-20 Starogardzkie Zaklady Farmaceutyczne Polfa Przedsiebiorstwo Panstwowe, Starogard Gdanski (Polen) Verfahren zur Herstellung von 1 -Nitro-9-(3'-dimethylaminopropylamino)-acridin-dihydrochlorid
US3897435A (en) * 1968-08-31 1975-07-29 Starogadzkie Zaklady Farmaceut N-oxides of 1 -nitro-9-dialkylaminoalkylamino/acridine
CH517096A (de) * 1968-08-31 1971-12-31 Starogardzkie Zakl Farma Verfahren zur Herstellung neuer, biologisch aktiver 1-Nitro-9-(dialkyl-aminoalkylamino)-akridin-N10-oxide

Also Published As

Publication number Publication date
US4150231A (en) 1979-04-17
SU683617A3 (ru) 1979-08-30
DE2713103A1 (de) 1977-10-13
HU173105B (hu) 1979-02-28
FR2347350A1 (fr) 1977-11-04
BE852855A (fr) 1977-07-18
JPS5527908B2 (enExample) 1980-07-24
NL7703680A (nl) 1977-10-10
SU682127A3 (ru) 1979-08-25
FR2347350B1 (enExample) 1980-02-01
CH634561A5 (de) 1983-02-15
GB1579588A (en) 1980-11-19
SE7703979L (sv) 1977-10-07
PL101032B1 (pl) 1978-11-30
DE2713103C2 (de) 1982-02-04
JPS52151178A (en) 1977-12-15

Similar Documents

Publication Publication Date Title
DK56077A (da) Fremgangsmade til fremstilling af 3-quinolincarboxylsyrederivater eller additionssalte deraf
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE435712B (sv) Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE435504B (sv) Analogiforfarande for framstellning av nya 1-nitro-9-alkylaminoalkylaminoakridiner och salter derav
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE7707749L (sv) Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
SE7707621L (sv) Forfarande for framstellning av xyloslosning
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE431655B (sv) Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat
SE7704311L (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner